Araki Hiroyuki, Matsukawa Hiroyoshi, Shiozaki Shigehiro, Satoh Daisuke, Yoshida Kazuhiro, Miyoshi Hisanobu, Choda Yasuhiro, Tokumoto Noriaki, Kanazawa Takashi, Harano Masao, Ojima Yasutomo, Idani Hitoshi, Okajima Masazumi, Ninomiya Motoki
Dept. of Surgery, Hiroshima City Hiroshima Citizens Hospital.
Gan To Kagaku Ryoho. 2014 Nov;41(12):2095-7.
Surgical treatment of peritoneal recurrence (PR) of hepatocellular carcinoma (HCC) is still controversial. We report herein 3 cases of PR treated by surgical resection. Firstly, a 55-year-old woman presented with recurrences in the peritoneum and mediastinal lymph nodes 12 months after hepatectomy for ruptured HCC. After the administration of sorafenib, the mediastinal lesions shrank and the PRs were resected. There has been no recurrence 20 months after PR resection. The second case was of a 56-year-old man with recurrences in the remnant liver and the peritoneum 41 months after hepatectomy for ruptured HCC. The remnant liver lesions were controlled by transcatheter arterial chemoembolization (TACE), and the PRs were resected twice. However, multiple bone and lung metastases developed and the patient died of HCC 73 months after peritoneal resection. In the third case, a 63-year-old man had recurrences in the remnant liver and the peritoneum 78 months after hepatectomy. Remnant liver lesions were controlled by radiofrequency ablation (RFA) and TACE, and PRs were resected. However, the hepatic lesions had progressed and he died 102 months after initial hepatectomy. Based on our observations, patients with PRs who have no other distant metastases and whose intrahepatic lesions are controllable and PRs are completely resectable may have relatively long-term survival. Surgical treatment of PR may also improve the quality of life and prognosis.
肝细胞癌(HCC)腹膜复发(PR)的外科治疗仍存在争议。我们在此报告3例接受手术切除治疗的PR病例。首先,一名55岁女性在因破裂性HCC行肝切除术后12个月出现腹膜和纵隔淋巴结复发。在使用索拉非尼后,纵隔病变缩小,PR被切除。PR切除后20个月未出现复发。第二例是一名56岁男性,在因破裂性HCC行肝切除术后41个月出现残余肝和腹膜复发。残余肝病变通过经动脉化疗栓塞术(TACE)得到控制,PR被切除两次。然而,出现了多处骨和肺转移,患者在腹膜切除术后73个月死于HCC。第三例,一名63岁男性在肝切除术后78个月出现残余肝和腹膜复发。残余肝病变通过射频消融(RFA)和TACE得到控制,PR被切除。然而,肝内病变进展,他在初次肝切除术后102个月死亡。基于我们的观察,没有其他远处转移、肝内病变可控且PR可完全切除的PR患者可能有相对长期的生存。PR的外科治疗也可能改善生活质量和预后。